These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8380297)

  • 21. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro.
    Rodloff AC; Becker J; Blanchard DK; Klein TW; Hahn H; Friedman H
    Infect Immun; 1986 May; 52(2):488-92. PubMed ID: 3699894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA; Quinto J; Kao J; Rotstein OD
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1985 Jan; 38(1):86-91. PubMed ID: 3881478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous injection of mice with bacteroides fragilis and Escherichia coli: role of Thioglycollate medium in the infectious process.
    Rodloff AC; Rodloff S; Fischer B; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 May; 254(3):405-12. PubMed ID: 6372324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
    Soriano F; Ponte C; Santamaría M; Castilla C
    J Antimicrob Chemother; 1989 Mar; 23(3):383-8. PubMed ID: 2659565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preexposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    J Infect Dis; 1991 Mar; 163(3):664-7. PubMed ID: 1995742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional and systemic immune responses in a murine model of empyema.
    Naziri W; Appel S; Trachtenberg L; Polk HC
    Surg Gynecol Obstet; 1993 Oct; 177(4):361-5. PubMed ID: 8211579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superoxide production of peritoneal macrophages in experimental gram-negative sepsis; influence of in vitro and in vivo supplements of zinc.
    Srinivas U; Jeppsson B; Braconier JH
    APMIS; 1989 Aug; 97(8):682-8. PubMed ID: 2548541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy in polymicrobial infections in a mouse model of type 2 diabetes.
    Mastropaolo MD; Evans NP; Byrnes MK; Stevens AM; Robertson JL; Melville SB
    Infect Immun; 2005 Sep; 73(9):6055-63. PubMed ID: 16113326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pure or combined inocula of Escherichia coli and Bacteroides fragilis on the liver and related metabolism.
    Rink RD; Kaelin CR; Raque G; Trachtenberg LS; Fry DE
    Lab Invest; 1982 Mar; 46(3):282-7. PubMed ID: 7038296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.
    Stearne LE; Kooi C; Goessens WH; Bakker-Woudenberg IA; Gyssens IC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):243-51. PubMed ID: 11120973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoassay for Bacteroides fragilis infections.
    Hoppes WL; Rissing JP; Smith JW; White AC
    J Clin Microbiol; 1980 Aug; 12(2):205-7. PubMed ID: 6164689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli.
    Dezfulian M; Bitar RA; Bartlett JG
    Chemotherapy; 1993; 39(5):355-60. PubMed ID: 8370326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of a specific bacterial antigen in urine of rats with Bacteroides fragilis infection.
    Rissing JP; Buxton TB; Harris RW; Shockley RK; Craven P; Moore WL
    J Lab Clin Med; 1983 Sep; 102(3):392-9. PubMed ID: 6886522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH.
    Sawyer RG; Spengler MD; Adams RB; Pruett TL
    Ann Surg; 1991 Mar; 213(3):253-60. PubMed ID: 1998406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
    Hau T; Jacobs DE; Hawkins NL
    Arch Surg; 1986 Feb; 121(2):163-8. PubMed ID: 3511886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A peritonitis model with low mortality and persisting intra-abdominal abscesses.
    Buyne OR; Bleichrodt RP; Verweij PE; Groenewoud HM; van Goor H; Hendriks T
    Int J Exp Pathol; 2006 Oct; 87(5):361-8. PubMed ID: 16965563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.